Belite Bio (BLTE) Enterprise Value (2021 - 2025)

Belite Bio's Enterprise Value history runs 5 years deep, the most recent figure standing at -$155.1 million for Q4 2025.

• On a quarterly basis, Enterprise Value fell 328.23% year-over-year to -$155.1 million in Q4 2025; TTM through Dec 2025 was -$155.1 million, a 328.23% decrease from a year earlier, with the FY2025 full-year figure at -$155.1 million, down 328.23% from the prior year.
• Enterprise Value improved to -$155.1 million in Q4 2025 per BLTE's latest filing, from -$157.0 million in the prior quarter.
• Across five years, Enterprise Value topped out at -$17.3 million in Q4 2021 and bottomed at -$157.0 million in Q3 2025.
• The 5-year median for Enterprise Value is -$65.1 million (2022), against an average of -$82.7 million.
• Across the five-year window, Enterprise Value surged 58.91% in 2024 and tumbled 328.23% in 2025, its largest moves.
• Year by year, Enterprise Value stood at -$17.3 million in 2021, then plunged by 142.67% to -$42.1 million in 2022, then sank by 109.45% to -$88.2 million in 2023, then surged by 58.91% to -$36.2 million in 2024, then plunged by 328.23% to -$155.1 million in 2025.
• Per Business Quant, the three latest BLTE Enterprise Value figures stand at -$155.1 million (Q4 2025), -$157.0 million (Q3 2025), and -$36.2 million (Q4 2024).